Tumour‐associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses
Satwinder Singh(Central University of Punjab), Yvette van Kooyk(Amsterdam University Medical Centers), Eiríkur Saeland(Janssen (Netherlands)), Manja Litjens(Utrecht University), Hakan Kalay(Amsterdam UMC Location Vrije Universiteit Amsterdam), Ingeborg Streng‐Ouwehand(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 41
Related Papers
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB
|Immunity|2007|573
Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk
|Nature Immunology|2009|482
The tumour glyco-code as a novel immune checkpoint for immunotherapy
|Nature reviews. Immunology|2018|470